Early screening for type 1 diabetes risk in newborns
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study screens very young infants (under 6 weeks old) to find those at high risk for type 1 diabetes. The goal is to identify babies who may be able to join future prevention trials.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be between 0 and 6 weeks old when the screening is done.
- You (the parent or guardian) must sign a consent form agreeing to the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study screens brothers, sisters, and children of people with type 1 diabetes to find early signs of the disease before symptoms appear. The goal is to catch it early and offer monitoring or future prevention options.
This study screens close family members of people with type 1 diabetes for early signs of the condition. A simple blood test looks for special markers (autoantibodies) that can show if the immune system is starting to attack the pancreas. Finding these markers early may help doctors prevent or delay the onset of diabetes.
This trial is looking for children with newly diagnosed type 1 diabetes to study how to detect the condition earlier. It focuses on kids who have already reached the stage where symptoms appear, to improve understanding of the disease.
This study screens high-risk children for early signs of type 1 diabetes by testing relatives who already have the condition. It aims to catch diabetes early so treatment can start sooner.
This study tests whether a program of diet and activity advice for families can lower the risk of type 1 diabetes in infants who have a higher genetic chance of developing it. It aims to find simple, everyday ways to help protect your child.
This study estimates the chance of developing type 1 diabetes in children by using information gathered during regular well-child visits. It may help identify children who could benefit from earlier monitoring.
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.